Mavissakalian M
Department of Psychiatry, Ohio State University, College of Medicine, Columbus 43210-1228.
J Psychiatr Res. 1993;27 Suppl 1:179-91. doi: 10.1016/0022-3956(93)90027-y.
There are few controlled studies of combined behavioral-pharmacological treatments of agoraphobia with panic. This review of the empirical evidence from studies using exposure in vivo as the behavioral modality and imipramine as the pharmacological agent suggests that these treatments have mutually potentiating effects in this disorder.
关于广场恐怖症伴惊恐发作的行为-药物联合治疗，几乎没有对照研究。这篇对以体内暴露为行为方式、丙咪嗪为药物的研究中的实证证据进行的综述表明，这些治疗方法对该疾病具有相互增强的作用。
